These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 1484744
1. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin]. Cohen R, Barre J, Varon E. Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744 [Abstract] [Full Text] [Related]
2. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci]. Bezian MC, Ribou G, Masquelier B. Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667 [Abstract] [Full Text] [Related]
3. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I. Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403 [Abstract] [Full Text] [Related]
4. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. Drago L, Nicola L, De Vecchi E. Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336 [Abstract] [Full Text] [Related]
5. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
6. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL, Kiffer CR, Mendes CM, Nicolau DP. Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [Abstract] [Full Text] [Related]
7. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method. Thamlikitkul V. J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906 [Abstract] [Full Text] [Related]
8. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics. Kolár M, Vágnerová I, Látal T, Kohnová I. Acta Univ Palacki Olomuc Fac Med; 1999 Dec; 142():69-71. PubMed ID: 10743728 [Abstract] [Full Text] [Related]
9. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)]. Kayaokay Y, Hasçelik G, Gür D, Akalin E. Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050 [Abstract] [Full Text] [Related]
10. [Determination of the susceptibility of staphylococci and enterococci to plycopeptides by the E-test method]. Plotton N, Cavallo JD, Crenn Y, Meyran M. Pathol Biol (Paris); 1994 May; 42(5):468-70. PubMed ID: 7824315 [Abstract] [Full Text] [Related]
12. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns. Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC. Drugs; 1997 Dec; 54 Suppl 6():11-20. PubMed ID: 9474477 [Abstract] [Full Text] [Related]
13. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J. J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [Abstract] [Full Text] [Related]
14. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine]. Rudy M, Nowakowska M, Wiechuła B, Zientara M, Radosz-Komoniewska H. Przegl Lek; 2004 Jun; 61(5):473-6. PubMed ID: 15515808 [Abstract] [Full Text] [Related]
15. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance]. Serazin V, Mougeot C, Libert JM. Pathol Biol (Paris); 1994 Apr; 42(4):323-7. PubMed ID: 7808785 [Abstract] [Full Text] [Related]
16. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group. Felmingham D, Brown DF, Soussy CJ. Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397 [Abstract] [Full Text] [Related]
17. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin. Guzek A, Korzeniewski K, Nitsch-Osuch A, Rybicki Z, Prokop E. Adv Exp Med Biol; 2013 Aug; 788():125-32. PubMed ID: 23835969 [Abstract] [Full Text] [Related]
18. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. Vouillamoz J, Moreillon P, Giddey M, Entenza JM. J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515 [Abstract] [Full Text] [Related]
19. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources. Jensen KT, Schønheyder H, Pers C, Thomsen VF. APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201 [Abstract] [Full Text] [Related]
20. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999]. Nashev D, Toshkova K, Gavrilova V. Vutr Boles; 2000 Jun; 32(2):35-40. PubMed ID: 11227664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]